Yali Capital has led the Series A funding round for healthcare firm 4baseCare, resulting in a total of $6 million raised.
The funds will be utilized to improve the range of products and expand operations to facilitate continued growth in India, as well as other Asian and Middle Eastern countries.
4baseCare provides precision oncology solutions utilizing state-of-the-art genetics and digital health technology. The genomic tests have had a significant influence in Southeast Asia, affecting more than 10,000 cancer patients.
Read also – Travel-tech Startup Ziptrrip Secures Rs 2Cr Pre-Seed Funding Round
The company offers genomic-based tests, including Indiegene, which is touted as the first cancer gene panel specifically designed for biomarker testing in the Indian population.
4baseCare plans to establish genomics laboratories in the Philippines, Nepal, and Dubai. In addition, the company will prioritize the development of genomics and digital health solutions, with a specific emphasis on sophisticated data analytics, enhanced clinical insights, and therapeutic suggestions based on data analysis.
About 4baseCare
Founded in 2018 by Hitesh Goswami, 4baseCare, an Illumina-backed Company* headquartered in Singapore, is engaged in developing cutting-edge Precision Oncology Solutions using Advanced Genomics and Next-Gen digital health technology.
Want to go deeper into the world of startups and entrepreneurship? Check out these categories on VIESTORIES:
Startup Success Stories: Discover inspiring tales of startups overcoming challenges and achieving success.
Funding Startup News: Stay updated with the latest news and trends in startup funding and investment.
Startup Insights: Dive into in-depth analyses of various industries and market trends to make informed business decisions.
